In this issue:
Radioembolisation with Y90-resin microspheres then nivolumab for advanced HCC
Mortality and survival trends of primary liver cancer in the US
MAIT cell tumour infiltration predicts cholangiocarcinoma long-term survival
DAAs for HCV-related recurrent HCC after multiple recurrences
Prediction model for HCC in HCV-infected patients in the DAA era
Downstaging outcomes for HCC
Association of aspirin and statin use with liver cancer risk in chronic HBV
Deep learning for predicting microvascular invasion in HCC
Detection of cholangiocarcinoma by biliary methylation markers in PSC
Please login below to download this issue (PDF)